Stergiou Angelos M.
President and CEO at SLS
- Sold, on record
- $570k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Nov 18, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SLSSELLAS Life Sciences Group, Inc.President and CEO
Sales by reason
0
Routine
0
Plan not stated
1
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale SLSPlan not statedDec 31 2018
Sold 23,277 shares at $1.25 ($29k)
Stergiou Angelos M., President and CEO
Sold 5.2% of holdings ($563k position)426,858 shares leftFirst sale on recordFiling
- 2 Form 4 sale SLSPlan not statedDec 2 +1067 days
Sold 2,120 shares at $6.25 ($13k)
Stergiou Angelos M., President and CEO
Sold 1.7% of holdings ($771k position)121,167 shares leftFirst sale on recordFiling
- 3 Form 4 sale SLSPlan not statedDec 5 +368 days
Sold 6,494 shares at $2.61 ($17k)
Stergiou Angelos M., President and CEO
Sold 3.9% of holdings ($439k position)161,689 shares leftFiling
- 4 Form 4 sale SLSNo planNov 18 +1444 days
Sold 26,606 shares at $19.18 ($510k)
Stergiou Angelos M., President and CEO
No 10b5-1 planSold 1.5% of holdings ($33.8M position)1.7M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2026 | SLS | President and CEO | Form 4 sale | 26,606 | $510k | 1.5% | No plan | SEC |
| Dec 5, 2022 | SLS | President and CEO | Form 4 sale | 6,494 | $17k | 3.9% | Plan not stated | SEC |
| Dec 2, 2021 | SLS | President and CEO | Form 4 sale | 2,120 | $13k | 1.7% | Plan not stated | SEC |
| Dec 31, 2018 | SLS | President and CEO | Form 4 sale | 23,277 | $29k | 5.2% | Plan not stated | SEC |